Fever in Cancer Treatment: Coley's Therapy and Epidemiologic Observations

Hall SS . A commotion in the blood: life, death, and the immune System. New York: Henry Holt and Company; 1997.

Coley WB . The treatment of malignant tumors by repeated inoculations of erysipelas: with a report of ten original cases. Am J Med Sci. 1893 May; 105(5): 487–510.

Busch VI . Verhandlungen ärztlicher Gesellschaften. Berliner Klin Wochenschrift. 1866;3:245–246.

Nauts HC . Bacteria and cancer-antagonisms and benefits. Cancer Surv. 1989; 8(4): 713–23.

O'Regan B , Hirshberg C . Spontaneous remission: an annotated bibliography. Sausalito: Institute of Noetic Sciences; 1993.

Fehleisen F . Über die Züchtung der Erysipelkokken auf künstlichem Nährboden und ihre Übertragbarkeit auf den Menschen. Dtsch Med Wschr. 1882; 8: 553–4.

Huth E . Leukämie und Infektion. Kinderärztliche Praxis. 1957; 25: 448–56.

Stephenson HE Jr , Delmez JA , Renden DI Host immunity and spontaneous regression of cancer evaluated by computerized data reduction study. Surg Gynecol Obstet. 1971 Oct; 133(4): 649–55.

Maurer S , Kölmel KF . Spontaneous regression of malignant melanoma. New York: Cancer Research Institute; 1997.

Wiernik PH . Spontaneous regression of lymphoma. 1–14. 1997. Albert Einstein Cancer Center and Montefiore Medical Center. Ref Type: Report.

Zygiert Z . Hodgkin's disease: remissions after measles. Lancet. 1971 Mar 20; 1(7699): 593.

Abdelrazeq AS . Spontaneous regression of colorectal cancer: a review of cases from 1900 to 2005. Int J Colorectal Dis. 2007 Jul; 22(7): 727–36.

Nauts HC . The beneficial effects of bacterial infections on host resistance to cancer. End results in 449 cases. 2nd ed. New York: Cancer Research Institute; 1980.

Coley WB . Late results of the treatment in inoperable sarcoma by the mixed toxins of erysipelas and bacillus prodigiosus. Am J Med Sci. 1906; 131(3): 375–430.

Nauts HC , Fowler A , Bogatko FH . A review of the influence of bacterial infection and of bacterial products (Coley's toxins) on malignant tumors in man; a critical analysis of 30 inoperable cases treated by Coley's mixed toxins, in which diagnosis was confirmed by microscopic examination selected for special study. Acta Med Scand Suppl. 1953; 276: 1–103.

Levine DB . The Hospital for the Ruptured and Crippled: William Bradley Coley, third Surgeon-in-Chief 1925-1933. HSS J. 2008 Feb; 4(1): 1–9.

Wiemann B , Starnes CO . Coley's toxins, tumor necrosis factor and cancer research: a historical perspective. Pharmacol Ther. 1994; 64(3): 529–64.

Pelner L , Fowler A . Host-tumor antagonism. XIII. Sarcoma of the soft tissues treated by bacterial toxins: successful series. J Am Geriatr Soc. 1959 Aug; 7(8):624–47.

Pelner L , Fowler A . Host-tumor antagonisms. XIV. Sarcoma of the soft tissues treated by bacterial toxins: unsuccessful series. J Am Geriatr Soc. 1959 Sep; 7:698–729.

Miller TR , Nicholson JT . End results in reticulum cell sarcoma of bone treated by bacterial toxin therapy alone or combined with surgery and/or radiotherapy (47 cases) or with concurrent injection (5 cases). Cancer. 1971 Mar; 27(3): 524–48.

Coley WB . Primary neoplasms of the lymphatic glands including Hodgkin's disease. Ann Surg. 1916 Jan; 63(1): 35–70.

Coley WB , Coley BL . Primary malignant tumors of the long bones: end results in 170 operable cases, including a small group of malignant central sarcoma. Arch Surg. 1926 Dec; 13(6): 779–836.

Nauts HC . Osteogenic sarcoma: End results following immunotherapy with bacterial vaccines 165 cases, or concurrent infections, inflammation or fever, 41 cases. New York: Cancer Research Institute; 1975.

Nauts HC . Beneficial effects of acute concurrent infection, inflammation, fever or immunotherapy (bacterial toxins) on ovarian and uterine cancer. New York: Cancer Research Institute; 1977.

Nauts HC . Breast cancer: immunological factors affecting incidence, prognosis and survival (Part I-III). New York: Cancer Research Institute; 1984.

Fowler GA , Nauts HC . The apparently beneficial effects of concurrent infections, inflammation or fever and of bacterial toxin therapy on neuroblastoma. New York: Cancer Research Institute; 1970.

Nauts HC . Enhancement of natural resistance to renal cancer: beneficial effects of concurrent infections and immunotherapy with bacterial vaccines. New York: Cancer Research Institute; 1973.

Fowler GA . Enhancement of natural resistance to malignant melanoma with special reference to the beneficial effects of concurrent infections and bacterial toxin therapy. New York: Cancer Research Institute; 1969.

Fowler GA . Testicular cancer treated by bacterial toxin therapy as a means of enhancing host resistance. New York: Cancer Research Institute; 1968.

Nauts HC . Beneficial effects of immunotherapy (bacterial toxins) on sarcoma of the soft tissues, other than lymphosarcoma. New York: Cancer Research Institute; 1975.

Fowler GA . Beneficial effects of acute bacterial infections or bacterial toxin therapy on cancer of the colon or rectum. New York: Cancer Research Institute; 1969.

Nauts HC . Ewing's sarcoma of bone: end results following immunotherapy (bacterial toxins) combined with surgery and/or radiation. New York: Cancer Research Institute; 1974.

Nauts HC . Multiple myeloma: beneficial effects of acute infections or immunotherapy (bacterial vaccines). New York: Cancer Research Institute; 1975.

Coley WB . The treatment of inoperable sarcoma by bacterial toxins (the mixed toxins of the streptococcus of erysipelas and the bacillus prodigiosus). The Practitioner. 1909; 83: 589–613.

Coley WB . The treatment of sarcoma with the mixed toxins of erysipelas and bacillus prodigiosus. Boston Med Surg J. 1908; 158(6): 175–82.

Coley WB . The treatment of inoperable sarcoma with the mixed toxins of erysipelas and bacillus prodigiosus. Med Record. 1917; 91: 965–6.

Coley WB . Erysipelas toxins and erysipelas serum in the treatment of inoperable malignant tumors: further observations. Med Record. 1895; 47(20): 609–12.

Johnston BJ . Clinical effect of Coley's toxin. I. A controlled study. Cancer Chemother Rep. 1962 Aug; 21:19–41.

Johnston BJ , Novales ET . Clinical effect of Coley's toxin. II. A seven-year study. Cancer Chemoth Rep. 1962 Aug; 21:43–68.

Kölmel KF , Vehmeyer K , Göhring E , Kuhn B , Wieding JU . Treatment of advanced malignant melanoma by a pyrogenic bacterial lysate. a pilot study. Onkologie. 1991; 14(5): 411–7.

Nauts HC . Pyrogen therapy of cancer: a historical overview and current activities. In: National Cancer Institute and American College of Radiology, editor. Proceedings of the International Symposium on Cancer Therapy by Hyperthermia and Radiation, Apr 28-30, 1975: 239–50.

Chandler JJ , Stark DB , Allen CV , Fletcher WS . Treatment of cancer by bacterial toxins. Am Surg. 1965 Jul; 31: 443–9.

Kempin S , Cirrencione C , Myers J Combined modality therapy of advanced nodular lymphomas (NL): The role of nonspecific immunotherapy (MBV) as an important determinant of responses and survival. Proc Am Soc Clin Oncol. 1983; 24: 56.

Kempin S , Cirrincione C , Straus DS Improved remission rate and duration in Nodular Non-Hodgkin Lymphoma (NNHL) with the use of mixed bacterial vaccine (MBV). Proc Am Assoc Cancer Res. 1981; 22: 514.

Oettgen HF , Old LJ , Hoffmann MK , Moore MA . Antitumor effects of endotoxin: possible mechanisms of action. In: Homma JY , editor. Bacterial endotoxin: chemical, biological and clinical aspects. Weinheim: Verlag Chemie; 1984. p. 205–22.

Tang ZY , Zhou HY , Zhao G Preliminary result of mixed bacterial vaccine as adjuvant treatment of hepatocellular carcinoma. Med Oncol Tumor Pharmacother. 1991; 8(1): 23–8.

Axelrod RS , Havas HF , Murasko DM , Bushnell B , Guan CF . Effect of the mixed bacterial vaccine on the immune response of patients with non-small cell lung cancer and refractory malignancies. Cancer. 1988 Jun 1; 61(11): 2219–30.

Havas HF , Axelrod RS , Burns MM , Murasko DM , Goonewardene M . Clinical results and immunologic effects of a mixed bacterial vaccine in cancer patients. Med Oncol Tumor Pharmacother. 1993; 10(4): 145–58.

Richardson MA , Ramirez T , Russell NC , Moye LA . Coley toxins immunotherapy: a retrospective review. Altern Ther Health Med. 1999 May; 5(3): 42–7.

Hoption Cann SA , van Netten JP , Van Netten C . Acute infections as a means of cancer prevention: opposing effects to chronic infections? Cancer Detect Prev. 2006; 30(1): 83–93.

Schmidt R . Krebs und Infektionskrankheiten. Med Klin. 1910; (43):1690–3.

Engel P . Über den Infektionsindex der Krebskrankheiten. Wien Klin Wochenschr. 1934; (37):1118–9.

Sinek F . Versuch einer statistischen Erfassung endogener Faktoren bei Carcinomkranken. Z Krebsforsch. 1936; 44: 492–527.

Güttich H . [Are tonsillectomized patients less subject to carcinoma of the upper respiratory and gastrointestinal tract?] HNO. 1960 Nov;9:47–9. German

Matzker J , Schmidt P . [On the problem of the relation between the tonsils and carcinoma of the respiratory and digestive tracts]. Z Laryngol Rhinol Otol. 1963 May; 42: 363–71. German.

West RO . Epidemiologic study of malignancies of the ovaries. Cancer. 1966 Jul; 19(7): 1001–7.

Wynder EL , Dodo H , Barber HR . Epidemiology of cancer of the ovary. Cancer. 1969 Feb; 22(2): 352–70.

Denk W , Karber K . [Studies on the possibility of immunoprophylaxis of carcinoma]. Österr Z Erforsch Bekampf Krebskr. 1970; 25(1): 30–9. German.

Witzel L . [History and other diseases in patients with malignant neoplasms]. Med Klin. 1970 May; 65(18): 876–9. German.

Joly DJ , Lilienfeld AM , Diamond EL , Bross ID . An epidemiologic study of the relationship of reproductive experience to cancer of the ovary. Am J Epidemiol. 1974 Mar; 99(3): 190–209.

Matzker J , Klasen HP . Tonsillektomie und Leukämie im Kindesalter. Laryngol Rhinol Otol (Stuttg). 1975; 54(12): 991–7.

Matzker J , Steinberg A . [Tonsillectomy and leukemia in adults (author's transl)]. Laryng Rhinol Otol (Stuttg). 1976 Sep; 55(9): 721–5. German.

Newhouse ML , Pearson RM , Fullerton JM , Boesen EAM , Shannon HS . A case control study of carcinoma of the ovary. Br J Prev Soc Med. 1977 Sep; 31(3): 148–53.

Jentgens H , Matzker J , Steinhaus C . [Frequency of tonsillectomy in bronchial cancer patients (author's transl)]. Laryng Rhinol Otol (Stuttg). 1978 Mar; 57(3): 190–3. German.

McGowan L , Parent L , Lednar W , Norris HJ . The woman at risk for developing ovarian cancer. Gynecol Oncol. 1979 Jun; 7(3): 325–4.

Grufferman S , Wang HH , DeLong ER , Kimm SYS , Delzell ES , Falletta JM . Environmental factors in the etiology of rhabdomyosarcoma in childhood. J Natl Cancer Inst. 1982 Jan; 68(1): 107–13.

Remy W , Hammerschmid K , Zänker KS Tumorträger haben selten Infekte in der Anamnese. Med Klin. 1983; 78(3): 95–8.

Ronne T . Measles virus infection without rash in childhood is related to disease in adult life. Lancet. 1985 Jan 5; 1(8419): 1–5.

van Steensel-Moll HA , Valkenburg HA , van Zanen GE . Childhood leukemia and infectious diseases in the first year of life: a register-based case-control study. Am J Epidemiol. 1986 Oct; 124(4): 590–4.

Chilvers C , Johnson B , Leach S , Taylor C , Vigar E . The common cold, allergy and cancer. Br J Cancer. 1986 Jul; 54(1): 123–6.

Grossarth-Maticek R , Frentzel-Beyme R , Kanazir D , Jankovic M , Vetter H . Reported herpes-virus-infection, fever and cancer incidence in a prospective study. J Chronic Dis. 1987; 40(10): 967–76.

Abel U , Becker N , Angerer R Common infections in the history of cancer patients and controls. J Cancer Res Clin Oncol. 1991; (117):339–44.

Kölmel KF , Gefeller O , Haferkamp B . Febrile infections and malignant melanoma: results of a case-control study. Melanoma Res. 1992 Sep; 2(3): 207–11.

Wrensch M , Weinberg A , Wiencke J Does prior infection with varicella-zoster virus influence risk of adult glioma? Am J Epidemiol. 1997 Apr 1;145(7):594–7.

Albonico HU , Bräker HU , Hüsler J . Febrile infectious childhood diseases in the history of cancer patients and matched controls. Med Hypotheses. 1998 Oct; 51(4): 315–20.

Mastrangelo G , Fadda E , Milan G . Cancer increased after a reduction of infections in the first half of this century in Italy: etiologic and preventive implications. Eur J Epidemiol. 1998 Dec; 14(8): 749–54.

Kölmel KF , Pfahlberg A , Mastrangelo G Infections and melanoma risk: results of a multicentre EORTC case-control study. Melanoma Res. 1999 Oct; 9(5): 511–9.

Schlehofer B , Blettner M , Preston-Martin S Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer. 1999 Jul 19; 82(2): 155–60.

Hoffmann C , Rosenberger A , Troger W , Buhring M . [Childhood diseases, infectious diseases, and fever as potential risk factors for cancer?] Forsch Komplementarmed Klass Naturheilkd. 2002 Dec;9(6):324–30; discussion 323. German.

Menegaux F , Olshan AF , Neglia JP , Pollock BH , Bondy ML . Day care, childhood infections, and risk of neuroblastoma. Am J Epidemiol. 2004 May 1; 159(9): 843–51.

Roman E , Simpson J , Ansell P Childhood acute lymphoblastic leukemia and infections in the first year of life: a report from the United Kingdom Childhood Cancer Study. Am J Epidemiol. 2007 Mar 1; 165(5): 496–504.

Cardwell CR , McKinney PA , Patterson CC , Murray LJ . Infections in early life and childhood leukaemia risk: a UK case-control study of general practitioner records. Br J Cancer. 2008 Nov 4; 99(9): 1529–33.

MacArthur AC , McBride ML , Spinelli JJ , Tamaro S , Gallagher RP , Theriault GP . Risk of childhood leukemia associated with vaccination, infection, and medication use in childhood: the Cross-Canada Childhood Leukemia Study. Am J Epidemiol. 2008 Mar 1; 167(5): 598–606.

Wrotek S , Kamecki K , Kwiatkowski S , Kozak W . Cancer patients report a history of fewer fevers during infections than healthy controls. J Preclin Clin Res. 2009; 3(1): 031–5.

Urayama KY , Buffler PA , Gallagher ER , Ayoob JM , Ma X . A meta-analysis of the association between day-care attendance and childhood acute lymphoblastic leukaemia. Int J Epidemiol. 2010 Jun; 39(3): 718–32.

Rudant J , Orsi L , Menegaux F Childhood acute leukemia, early common infections, and allergy: the ESCALE Study. Am J Epidemiol. 2010 Nov 1; 172(9): 1015–27.

Vestergaard H , Westergaard T , Wohlfahrt J , Hjalgrim H , Melbye M . Tonsillitis, tonsillectomy and Hodgkin's lymphoma. Int J Cancer. 2010 Aug 1; 127(3): 633–7.

Urayama KY , Ma X , Selvin S Early life exposure to infections and risk of childhood acute lymphoblastic leukemia. Int J Cancer. 2011 Apr 1; 128(7): 1632–43.

Cramer DW , Finn OJ . Epidemiologic perspective on immune-surveillance in cancer. Curr Opin Immunol. 2011 Apr; 23(2): 265–71.

Takita H . Effect of postoperative empyema on survival of patients with bronchogenic carcinoma. J Thorac Cardiovasc Surg. 1970 May; 59(5): 642–4.

LeRoux BT . Empyema thoracis. Br J Surg. 1965 Feb; 52: 89–99.

Sensenig DM , Rossi NP , Ehrenhaft JL . Results of the surgical treatment of bronchogenic carcinoma. Surg Gynecol Obstet. 1963 Mar; 116: 279–84.

Ruckdeschel JC , Codish SD , Stranaham A , McKneally MF . Postoperative empyema improves survival in lung cancer. Documentation and analysis of a natural experiment. N Engl J Med. 1972 Nov 16; 287(20): 1013–7.

McKneally MF , Maver C , Kausel HW . Regional immunotherapy of lung cancer with intrapleural B. C. G. Lancet. 1976 Feb 21; 1(7956): 377–9.

Cady B , Cliffton EE . Empyema and survival following surgery for bronchogenic carcinoma. J Thorac Cardiovasc Surg. 1967 Jan; 53(1): 102–8.

Minasian H , Lewis CT , Evans SJ . Influence of postoperative empyema on survival after pulmonary resection for bronchogenic carcinoma. Br Med J. 1978 Nov 11; 2(6148): 1329–31.

Brohee D , Vanderhoeft P , Smets P . Lung cancer and postoperative empyema. Eur J Cancer. 1977 Dec; 13(12): 1429–36.

Müller W , Regazzoni P . [Does a local postoperative infection improve the prognosis in colonic carcinoma?] Helv Chir Acta. 1975 Mar;42(1-2):205–8. German.

Fucini C , Bandettini L , D'Elia M , Filipponi F , Herd-Smith A . Are postoperative fever and/or septic complications prognostic factors in colorectal cancer resected for cure? Dis Colon Rectum. 1985 Feb; 28(2): 94–5.

Nowacki MP , Szymendera JJ . The strongest prognostic factors in colorectal carcinoma. Surgicopathologic stage of disease and postoperative fever. Dis Colon Rectum. 1983 Apr; 26(4): 263–8.

Papachristou DN , Fortner JG . Effect of postoperative wound infection on the course of stage II melanoma. Cancer. 1979 Mar; 43(3): 1106–11.

Jeys LM , Grimer RJ , Carter SR , Tillman RM , Abudu A . Post operative infection and increased survival in osteosarcoma patients: are they associated? Ann Surg Oncol. 2007 Oct; 14(10): 2887–95.

Teucher G , Schindler AE . [Postoperative fever and prognosis in breast cancer]. Arch Geschwulstforsch. 1987; 57(4): 309–17. German.

Jackson RM , Rice DH . Wound infections and recurrence in head and neck cancer. Otolaryngol Head Neck Surg. 1990 Apr; 102(4): 331–3.

Grandis JR , Snyderman CH , Johnson JT , Yu VL , D'Amico F . Postoperative wound infections. A poor prognostic sign for patients with head and neck cancer. Cancer. 1992 Oct 15; 70(8): 2166–70.

Grivennikov SI , Greten FR , Karin M . Immunity, inflammation, and cancer. Cell. 2010 Mar 19; 140(6): 883–99.

Boyle P , Levin B International Agency for Research on Cancer. World cancer report 2008. Lyon: International Agency for Research on Cancer; 2008.

Coussens LM , Werb Z . Inflammation and cancer. Nature. 2002 Dec 19-26;420(6917): 860–7.

Ryan SO , Gantt KR , Finn OJ . Tumor antigen-based immunotherapy and immuno-prevention of cancer. Int Arch Allergy Immunol. 2007; 142(3): 179–89.

Sporn MB , Roberts AB . Peptide growth factors are multifunctional. Nature. 1988 Mar 17; 332(6161): 217–9.

Nathan C , Sporn MB . Cytokines in context. J Cell Biol. 1991 Jun; 113(5): 981–6.

Silverstein AM . A history of immunology. San Diego, New York, Boston, London, Sydney, Tokyo, Toronto: Academic Press; 1989.

Hewitt HB . Animal tumor models and their relevance to human tumor immunology. J Biol Response Modif. 1982; 1(2): 107–19.

Nossal GJ . The case history of Mr. T.I. Terminal patient or still curable? Immunol Today. 1980 Jul; 1(1): 5–9.

Hewitt HB , Blake ER , Walder AS . A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneus origin. Br J Cancer. 1976 Mar; 33(3): 241–59.

Shear MJ , Turner FC , Perrault A , Shovelton T . Chemical treatment of tumors. V. Isolation of the hemorrhage-producing fraction from Serratia marcescens (Bacillus prodigiosus) culture filtrate. J Natl Cancer Inst. 1943; 4: 81–97.

Carswell EA , Old LJ , Kassel RL , Green S , Fiore N , Williamson B . An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA. 1975 Sep; 72(9): 3666–70.

Old LJ . Tumor necrosis factor (TNF). Science. 1985 Nov 8; 230(4726): 630–2.

Tsung K , Norton JA . Lessons from Coley's toxin. Surg Oncol. 2006 Jul; 15(1): 25–8.

Decker WK , Safdar A . Bioimmunoadjuvants for the treatment of neoplastic and infectious disease: Coley's legacy revisited. Cytokine Growth Factor Rev. 2009 Aug; 20(4): 271–81.

Finn OJ . Cancer immunology. N Engl J Med. 2008 Jun 19; 358(25): 2704–15.

Matzinger P . The danger model: a renewed sense of self. Science. 2002 Apr 12; 296(5566): 301–5.

Hobohm U . Fever and cancer in perspective. Cancer Immunol Immunother. 2001 Oct; 50(8): 391–6.

Baronzio G , Gramaglia A , Fiorentini G . Hyperthermia and immunity. A brief overview. In Vivo. 2006 Nov-Dec;20(6A):689–95.

Fisher DT , Vardam TD , Muhitch JB , Evans SS . Fine-tuning immune surveillance by fever-range thermal stress. Immunol Res. 2010 Mar;46(1-3): 177–88.

Hasday JD , Singh IS . Fever and the heat shock response: distinct, partially overlapping processes. Cell Stress Chaperones. 2000 Nov; 5(5): 471–80.

Skitzki JJ , Repasky EA , Evans SS . Hyperthermia as an immunotherapy strategy for cancer. Curr Opin Investig Drugs. 2009 Jun; 10(6): 550–8.

Roti Roti JL . Cellular responses to hyperthermia (40-46 degrees C): Cell killing and molecular events. Int J Hyperthermia. 2008 Feb; 24(1): 3–15.

Wust P , Hildebrandt B , Sreenivasa G Hyperthermia in combined treatment of cancer. Lancet Oncol. 2002 Aug; 3(8): 487–97.

Issels RD , Lindner LH , Verweij J Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol. 2010 Jun; 11(6): 561–70.

Zacharski LR , Sukhatme VP . Coley's toxin revisited: immunotherapy or plasminogen activator therapy of cancer? J Thromb Haemost. 2005 Mar; 3(3): 424–7.

Bonn D . Biocomplexity: look at the whole, not the parts. Lancet. 2001 Jan 27; 357(9252): 288.

Orosz CG . An introduction to immunoecology and immuno-informatics. In: Segel LA , Cohen IR , editors. Design principles for the immune system and other distributed autonomous systems. Oxford, New York: Oxford University Press; 2001. p. 125–49.

Kienle GS , Kiene H . “Beyond reductionism”—zur Notwendigkeit komplexer, organismischer Ansätze in der Tumorimmunologie und Onkologie. In: Kienle GS , Kiene H , editors. Die Mistel in der Onkologie. Fakten und konzeptionelle Grundlagen. Stuttgart, New York: Schattauer Verlag; 2003:333–432.

Horrobin DF . Effective clinical innovation: an ethical imperative. Lancet. 2002 May 25; 359(9320): 1857–8.

Horrobin DF . Are large clinical trials in rapidly lethal diseases usually unethical? Lancet. 2003 Feb 22;361(9358):695–7.

Horrobin DF . Innovation in the pharmaceutical industry. J R Soc Med. 2000 Jul; 93(7): 341–5.

Drews J . In quest of tomorrow's medicines. Berlin, Heidelberg, New York: Springer; 2003.

Angell M . The truth about drug companies. New York: Random House; 2004.

Shaywitz DA , Ausiello DA . Preserving creativity in medicine. PLoS Med. 2004 Dec; 1(3): e34.

Kienle GS , Kiene H . Clinical judgement and the medical profession. J Eval Clin Pract. 2011 Aug; 17(4): 621–7.